Protective Effect of Ferulic Acid on Acetylcholinesterase and Amyloid Beta Peptide Plaque Formation in Alzheimer's Disease: An In Vitro Study

被引:13
作者
Mugundhan, Varsha [1 ]
Arthanari, Abirami [1 ]
Parthasarathy, Parameswari R. [2 ]
机构
[1] Saveetha Univ, Saveetha Dent Coll & Hosp, Saveetha Inst Med & Tech Sci, Dept Forens Odontol, Chennai, India
[2] Saveetha Univ, Saveetha Dent Coll & Hosp, Saveetha Inst Med & Tech Sci, Dept Pharmacol, Chennai, India
关键词
neuroprotection; antioxidant; ferulic acid; amyloid; acetylcholinesterase; alzheimer's disease; OXIDATIVE STRESS; IMPAIRMENT; NEURONS; MODELS;
D O I
10.7759/cureus.54103
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim This study aims to comprehensively evaluate the effects of ferulic acid (FA) on acetylcholinesterase (AChE) enzyme activity and amyloid beta (A beta) peptide plaque formation in an in vitro model of Alzheimer's disease (AD). Background AD is a progressive neurological condition marked by disrupted cholinergic signaling, accumulation of A beta peptide, and tau protein hyperphosphorylation. Currently, no direct anti -Alzheimer drug that effectively prevents the cognitive decline from AD has been reported. To combat this, a multi -target drug addressing several molecular aspects would be ideal for AD. Natural compounds are preferred over synthetic drugs due to their accessibility, cost -efficiency, and lower toxicity The proven association between polyphenol consumption and the prevention of AD has led to the investigation of the effect of FA, a polyphenolic compound, on acetylcholinesterase enzyme activity and A beta peptide formation, the key targets of AD. Materials and method The free radical scavenging ability of FA was assessed by xanthine oxidase inhibitory activity. Furthermore, FA was also evaluated for its inhibitory activity against AChE enzyme and amyloid beta peptide formation to evaluate the neuroprotective potential of FA. Results The results showed that FA has the potential to be an AChE inhibitor, thus helping in blocking the activity of AChE and also reducing the incidence of amyloid beta plaque formation. Furthermore, the compound also exhibited a significant antioxidant property which was demonstrated by the xanthine oxidase enzyme inhibitory effect. Conclusion From the observed results, FA has significant antioxidant and neuroprotective effects which are compared with those of their respective standards. More research is required to determine the efficacy and safety of this compound as a treatment for neurodegenerative diseases like AD because the precise mechanism and degree of its AChE inhibitory effects in the brain are still elusive. A potent, selective, and effective drug is desperately needed to treat patients with AD and those at risk of developing the disease.
引用
收藏
页数:9
相关论文
共 50 条
[41]   Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer’s disease? [J].
Tamas Fulop ;
Jacek M. Witkowski ;
Anis Larbi ;
Abdelouahed Khalil ;
Georges Herbein ;
Eric H. Frost .
Journal of NeuroVirology, 2019, 25 :634-647
[42]   Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation [J].
Ashrafian, Hossein ;
Zadeh, Elaheh Hadi ;
Khan, Rizwan Hasan .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 167 :382-394
[43]   Study on the removal of amyloid plaque by nano-gold in the treatment of neurodegenerative disease-alzheimer's disease [J].
Chai, Hongyan ;
Wang, Xueyong ;
Liu, Zhimin ;
Zhao, Yuehan .
MATERIALS EXPRESS, 2021, 11 (07) :1038-1044
[44]   The use of formic acid to embellish amyloid plaque detection in Alzheimer's disease tissues misguides key observations [J].
D'Andrea, MR ;
Reiser, PA ;
Polkovitch, DA ;
Gumula, NA ;
Branchide, B ;
Hertzog, BM ;
Schmidheiser, D ;
Belkowski, S ;
Gastard, MC ;
Andrade-Gordon, P .
NEUROSCIENCE LETTERS, 2003, 342 (1-2) :114-118
[45]   The turn formation at positions 22 and 23 in the 42-mer amyloid β peptide: The emerging role in the pathogenesis of Alzheimer's disease [J].
Murakami, Kazuma ;
Masuda, Yuichi ;
Shirasawa, Takuji ;
Shimizu, Takahiko ;
Irie, Kazuhiro .
GERIATRICS & GERONTOLOGY INTERNATIONAL, 2010, 10 :S169-S179
[46]   Mutant ubiquitin decreases amyloid β plaque formation in a transgenic mouse model of Alzheimer's disease [J].
van Tijn, Paula ;
Dennissen, Frank J. A. ;
Gentier, Romina J. G. ;
Hobo, Barbara ;
Hermes, Denise ;
Steinbusch, Harry W. M. ;
Van Leeuwen, Fred W. ;
Fischer, David F. .
NEUROCHEMISTRY INTERNATIONAL, 2012, 61 (05) :739-748
[47]   Microglia and amyloid plaque formation in Alzheimer's disease - Evidence, possible mechanisms, and future challenges [J].
Fruhwurth, Stefanie ;
Zetterberg, Henrik ;
Paludan, Soren R. .
JOURNAL OF NEUROIMMUNOLOGY, 2024, 390
[48]   Gallotannins and Tannic Acid: First Chemical Syntheses and In Vitro Inhibitory Activity on Alzheimer's Amyloid -Peptide Aggregation [J].
Sylla, Tahiri ;
Pouysegu, Laurent ;
Da Costa, Gregory ;
Deffieux, Denis ;
Monti, Jean-Pierre ;
Quideau, Stephane .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2015, 54 (28) :8217-8221
[49]   Neuroprotective Effect of Physical Exercise in a Mouse Model of Alzheimer's Disease Induced by β-Amyloid1-40 Peptide [J].
Souza, Leandro C. ;
Filho, Carlos B. ;
Goes, Andre T. R. ;
Del Fabbro, Lucian ;
de Gomes, Marcelo G. ;
Savegnago, Lucielli ;
Oliveira, Mauro Schneider ;
Jesse, Cristiano R. .
NEUROTOXICITY RESEARCH, 2013, 24 (02) :148-163
[50]   Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer’s disease mouse model with suppression of glymphatic clearance [J].
Weixi Feng ;
Yanli Zhang ;
Ze Wang ;
Hanrong Xu ;
Ting Wu ;
Charles Marshall ;
Junying Gao ;
Ming Xiao .
Alzheimer's Research & Therapy, 12